263 related articles for article (PubMed ID: 26813008)
21. Selenium and Type 2 Diabetes: Systematic Review.
Kohler LN; Foote J; Kelley CP; Florea A; Shelly C; Chow HS; Hsu P; Batai K; Ellis N; Saboda K; Lance P; Jacobs ET
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563119
[TBL] [Abstract][Full Text] [Related]
22. [Effects of zhenqing recipe and earthworm on the expressions of transforming growth factor-beta1 and plasminogen activator inhibitor 1 in renal tissues of type 2 diabetic rats].
Liu LF; Wen XY; Xu MW
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Jul; 31(7):967-72. PubMed ID: 21866671
[TBL] [Abstract][Full Text] [Related]
23. The roles of PAI-1 gene polymorphisms in atherosclerotic diseases: A systematic review and meta-analysis involving 149,908 subjects.
Liu Y; Cheng J; Guo X; Mo J; Gao B; Zhou H; Wu Y; Li Z
Gene; 2018 Oct; 673():167-173. PubMed ID: 29908999
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system.
Heiss MM; Babic R; Allgayer H; Gruetzner KU; Jauch KW; Loehrs U; Schildberg FW
J Clin Oncol; 1995 Aug; 13(8):2084-93. PubMed ID: 7636552
[TBL] [Abstract][Full Text] [Related]
25. The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies.
Roshanzamir F; Miraghajani M; Rouhani MH; Mansourian M; Ghiasvand R; Safavi SM
J Endocrinol Invest; 2018 Jan; 41(1):33-47. PubMed ID: 28643299
[TBL] [Abstract][Full Text] [Related]
26. Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence.
Kunutsor SK; Apekey TA; Walley J; Kain K
Diabetes Metab Res Rev; 2013 May; 29(4):308-18. PubMed ID: 23381919
[TBL] [Abstract][Full Text] [Related]
27. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D
Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958
[TBL] [Abstract][Full Text] [Related]
28. Association between type 2 diabetes (T2D) and tooth loss: a systematic review and meta-analysis.
Ahmadinia AR; Rahebi D; Mohammadi M; Ghelichi-Ghojogh M; Jafari A; Esmaielzadeh F; Rajabi A
BMC Endocr Disord; 2022 Apr; 22(1):100. PubMed ID: 35418054
[TBL] [Abstract][Full Text] [Related]
29. Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies.
Fang X; Han H; Li M; Liang C; Fan Z; Aaseth J; He J; Montgomery S; Cao Y
Nutrients; 2016 Nov; 8(11):. PubMed ID: 27869762
[TBL] [Abstract][Full Text] [Related]
30. Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis.
Jung RG; Motazedian P; Ramirez FD; Simard T; Di Santo P; Visintini S; Faraz MA; Labinaz A; Jung Y; Hibbert B
Thromb J; 2018; 16():12. PubMed ID: 29991926
[TBL] [Abstract][Full Text] [Related]
31. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis.
Zhao L; Bracken MB; Dewan AT; Chen S
Mol Hum Reprod; 2013 Mar; 19(3):136-43. PubMed ID: 23180602
[TBL] [Abstract][Full Text] [Related]
32. Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis.
Sujana C; Huth C; Zierer A; Meesters S; Sudduth-Klinger J; Koenig W; Herder C; Peters A; Thorand B
Eur J Endocrinol; 2018 Apr; 178(4):389-398. PubMed ID: 29439057
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia.
Tee YT; Wang PH; Tsai HT; Lin LY; Lin HT; Yang SF; Hsieh YH; Ying TH
J Surg Oncol; 2012 Aug; 106(2):204-8. PubMed ID: 22354580
[TBL] [Abstract][Full Text] [Related]
34. Association of iron indices and type 2 diabetes: a meta-analysis of observational studies.
Orban E; Schwab S; Thorand B; Huth C
Diabetes Metab Res Rev; 2014 Jul; 30(5):372-94. PubMed ID: 24327370
[TBL] [Abstract][Full Text] [Related]
35. Plasminogen activator inhibitor type 1 is the most significant of the usual tissue prognostic factors in node-negative breast ductal adenocarcinoma independent of urokinase-type plasminogen activator.
Descotes F; Riche B; Saez S; De Laroche G; Datchary J; Roy P; André J; Bobin JY
Clin Breast Cancer; 2008 Apr; 8(2):168-77. PubMed ID: 18621614
[TBL] [Abstract][Full Text] [Related]
36. Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).
Harbeck N; Kates RE; Look MP; Meijer-Van Gelder ME; Klijn JG; Krüger A; Kiechle M; Jänicke F; Schmitt M; Foekens JA
Cancer Res; 2002 Aug; 62(16):4617-22. PubMed ID: 12183417
[TBL] [Abstract][Full Text] [Related]
37. Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis.
Zhao Z; Li S; Liu G; Yan F; Ma X; Huang Z; Tian H
PLoS One; 2012; 7(7):e41641. PubMed ID: 22848554
[TBL] [Abstract][Full Text] [Related]
38. Impact of fibrate therapy on plasma plasminogen activator inhibitor-1: a systematic review and meta-analysis of randomized controlled trials.
Sahebkar A; Simental-Mendía LE; Watts GF; Golledge J
Atherosclerosis; 2015 May; 240(1):284-96. PubMed ID: 25828270
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
[TBL] [Abstract][Full Text] [Related]
40. Handgrip strength-A risk indicator for type 2 diabetes: Systematic review and meta-analysis of observational cohort studies.
Kunutsor SK; Isiozor NM; Khan H; Laukkanen JA
Diabetes Metab Res Rev; 2021 Feb; 37(2):e3365. PubMed ID: 32543028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
